Diagnostics

Diagnostics is a company sector tag on BioPharmSignal. This page groups public biotech and healthcare companies associated with Diagnostics, making it easier to scan related businesses, compare peers, and follow companies exposed to the same modality, disease area, or development theme.

Why watch Diagnostics

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Diagnostics news

The latest feed items from companies currently grouped under Diagnostics.

1. 01
   2026-10-06 13:19 EST

   BIAFbioAffinity Technologies Reports Over 100% Growth in CyPath® Lung Sales Through Third Quarter 2026

   Source: bioAffinity Technologies, Inc.

2. 02
   2026-10-01 12:52 EST

   DGXHaystack MRD® Demonstrates Robust Clinical Performance in Specimen Cohort from the Landmark DYNAMIC Colorectal Cancer Trials

   Source: Quest Diagnostics

3. 03
   2026-10-01 06:00 EST

   RHHBYRoche presents new data at EURETINA, highlighting Vabysmo’s real-world effectiveness and safety across major retinal conditions

   Source: Roche Holdings AG

4. 04
   2026-10-01 05:00 EST

   RHHBYRoche’s giredestrant combination significantly improved progression-free survival in ER-positive advanced breast cancer in phase III evERA data published in The New England Journal of Medicine

   Source: Roche Holdings AG

5. 05
   2026-09-30 12:00 EST

   BIAFbioAffinity Technologies Promotes Veteran Awareness and Access to Its Noninvasive CyPath® Lung Cancer Test Through Distribution Partnership with Veteran-Owned AvMEDICAL

   Source: bioAffinity Technologies, Inc.

6. 06
   2026-09-30 05:00 EST

   RHHBYRoche’s fenebrutinib is the first BTK inhibitor to receive U.S. FDA filing acceptance in both relapsing and primary progressive multiple sclerosis

   Source: Roche Holdings AG

7. 07
   2026-09-24 10:00 EST

   BDSXBiodesix Advances Two Complementary Approaches to Molecular Residual Disease (MRD) Monitoring

   Source: Biodesix

8. 08
   2026-09-23 05:15 EST

   RHHBYPositive interim data shows Roche’s sefaxersen significantly reduces proteinuria in people with IgA nephropathy (IgAN)

   Source: Roche Holdings AG

9. 09
   2026-09-23 05:00 EST

   RHHBYÄnderung im Verwaltungsrat von Roche

   Source: Roche Holdings AG

10. 10
    2026-09-23 05:00 EST

    RHHBYChange in Roche’s Board of Directors

    Source: Roche Holdings AG

11. 11
    2026-09-22 20:28 EST

    DGXQuest Diagnostics to Release Third Quarter Financial Results on October 22, 2026

    Source: Quest Diagnostics

12. 12
    2026-09-22 12:00 EST

    BIAFbioAffinity Technologies to Present Positive Clinical and Veteran-Focused Data on CyPath® Lung at NAVREF 2026 Annual Conference

    Source: bioAffinity Technologies, Inc.

13. 13
    2026-09-22 11:55 EST

    LUCDLucid Diagnostics Advances Multiple EsoGuard® and EsoCheck® Payment, Billing and Coding Pathways

    Source: Lucid Diagnostics

14. 14
    2026-09-22 05:00 EST

    RHHBY[Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase II results for dual GLP-1/GIP receptor agonist enicepatide in people living with type 2 diabetes and overweight or obesity

    Source: Roche Holdings AG

15. 15
    2026-09-21 15:45 EST

    RHHBYEuropean Commission approves Roche’s Susvimo® for the treatment of neovascular age-related macular degeneration (nAMD)

    Source: Roche Holdings AG

16. 16
    2026-09-21 12:03 EST

    DGXNearly 1 in 3 Patients with Suspected Lyme Disease are Co-Positive for Other Tick-Borne Pathogens, Finds Study by Quest Diagnostics

    Source: Quest Diagnostics

17. 17
    2026-09-18 10:45 EST

    RHHBYCHMP recommends EU approval of Roche’s Ocrevus for children and adolescents with relapsing multiple sclerosis

    Source: Roche Holdings AG

18. 18
    2026-09-17 18:30 EST

    RHHBYRoche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases

    Source: Roche Holdings AG

19. 19
    2026-09-17 12:00 EST

    BIAFbioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath® Lung Noninvasive Lung Cancer Diagnostic

    Source: bioAffinity Technologies, Inc.

20. 20
    2026-09-17 05:00 EST

    RHHBYRoche’s Lunsumio-based regimen significantly improves progression-free survival in follicular lymphoma in phase III CELESTIMO study

    Source: Roche Holdings AG

Companies in Diagnostics

39 companies tagged with Diagnostics.

Frequently Asked Questions